Deborah Mortensen
21Patents
10h-index
54Co-inventors
74Inventor score
Filing activity: Oct 18, 2007 → Apr 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7981893B2 | Heteroaryl compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 73 | Active |
| US8383634B2 | Methods of treatment using heteroaryl compounds and compositions thereof | Chemistry; Metallurgy | 45 | Active |
| US8492381B2 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Chemistry; Metallurgy | 41 | Active |
| US8110578B2 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Chemistry; Metallurgy | 39 | Active |
| US8372976B2 | Methods of treatment comprising the administration of heteroaryl compounds | Chemistry; Metallurgy | 38 | Active |
| US7968556B2 | Heteroaryl compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 30 | Active |
| US8569494B2 | Methods of synthesis and purification of heteroaryl compounds | Chemistry; Metallurgy | 19 | Active |
| US8507492B2 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway | Chemistry; Metallurgy | 18 | Active |
| US9155736B2 | Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity | Physics | 17 | Active |
| US9556126B2 | Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 10 | Active |
| US9771371B2 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9156798B2 | Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 4 | Active |
| US9079900B2 | Methods of synthesis and purification of heteroaryl compounds | Chemistry; Metallurgy | 4 | Active |
| US8907087B2 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9783505B2 | Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith | Chemistry; Metallurgy | 2 | Active |
| US10167290B2 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11292796B2 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12404239B2 | Modulators of BCL6 as ligand directed degraders | Chemistry; Metallurgy | 0 | Active |
| US9557338B2 | Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for tor kinase inhibitory activity | Physics | 0 | Active |
| US10683298B2 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9193692B2 | Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.